ALPS Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $587K | Buy |
1,109
+10
| +0.9% | +$4.62K | ﹤0.01% | 909 |
|
|
2026
Q1 | $528K | Buy |
+1,099
| New | +$563K | ﹤0.01% | 725 |
|
|
2025
Q4 | – | Sell |
-929
| Closed | -$478K | – | 1047 |
|
|
2025
Q3 | $478K | Sell |
929
-182
| -16% | -$79.5K | ﹤0.01% | 701 |
|
|
2025
Q2 | $349K | Buy |
1,111
+13
| +1% | +$3.9K | ﹤0.01% | 873 |
|
|
2025
Q1 | $335K | Buy |
1,098
+100
| +10% | +$33.6K | ﹤0.01% | 859 |
|
|
2024
Q4 | $332K | Hold |
998
| – | – | ﹤0.01% | 831 |
|
|
2024
Q3 | $333K | Buy |
998
+140
| +16% | +$53.2K | ﹤0.01% | 911 |
|
|
2024
Q2 | $353K | Hold |
858
| – | – | ﹤0.01% | 724 |
|
|
2024
Q1 | $347K | Sell |
858
-289
| -25% | -$102K | ﹤0.01% | 848 |
|
|
2023
Q4 | $352K | Sell |
1,147
-65
| -5% | -$17.5K | ﹤0.01% | 760 |
|
|
2023
Q3 | $293K | Sell |
1,212
-599
| -33% | -$153K | ﹤0.01% | 889 |
|
|
2023
Q2 | $435K | Buy |
1,811
+10
| +0.6% | +$2.08K | ﹤0.01% | 648 |
|
|
2023
Q1 | $339K | Sell |
1,801
-262
| -13% | -$54.2K | ﹤0.01% | 720 |
|
|
2022
Q4 | $438K | Sell |
2,063
-5
| -0.2% | -$999 | ﹤0.01% | 622 |
|
|
2022
Q3 | $325K | Buy |
+2,068
| New | +$330K | ﹤0.01% | 686 |
|
|
2022
Q1 | – | Sell |
-2,032
| Closed | -$442K | – | 915 |
|
|
2021
Q4 | $442K | Buy |
2,032
+25
| +1% | +$5.24K | 0.01% | 562 |
|
|
2021
Q3 | $380K | Sell |
2,007
-78
| -4% | -$14.2K | ﹤0.01% | 612 |
|
|
2021
Q2 | $368K | Hold |
2,085
| – | – | ﹤0.01% | 635 |
|
|
2021
Q1 | $342K | Sell |
2,085
-97
| -4% | -$14.8K | ﹤0.01% | 636 |
|
|
2020
Q4 | $304K | Sell |
2,182
-66
| -3% | -$8.32K | ﹤0.01% | 704 |
|
|
2020
Q3 | $251K | Sell |
2,248
-535
| -19% | -$61.9K | ﹤0.01% | 772 |
|
|
2020
Q2 | $259K | Sell |
2,783
-309
| -10% | -$26.3K | ﹤0.01% | 618 |
|
|
2020
Q1 | $227K | Sell |
3,092
-981
| -24% | -$85.2K | ﹤0.01% | 678 |
|
|
2019
Q4 | $342K | Sell |
4,073
-177
| -4% | -$13.7K | ﹤0.01% | 748 |
|
|
2019
Q3 | $357K | Sell |
4,250
-2,970
| -41% | -$224K | ﹤0.01% | 666 |
|
|
2019
Q2 | $472K | Sell |
7,220
-380
| -5% | -$21.9K | ﹤0.01% | 540 |
|
|
2019
Q1 | $448K | Buy |
7,600
+517
| +7% | +$30.9K | ﹤0.01% | 555 |
|
|
2018
Q4 | $375K | Sell |
7,083
-587
| -8% | -$32.2K | ﹤0.01% | 652 |
|
|
2018
Q3 | $460K | Buy |
+7,670
| New | +$420K | ﹤0.01% | 826 |
|
Other funds holding MEDP
WA
ALPS Advisors's MEDP Position: Q2 2026 in Review
ALPS Advisors increased its Medpace (MEDP) stake by 0.91% in Q2 2026, buying an estimated $4.62K and bringing the position to 1,109 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #909.
ALPS Advisors first reported a position in MEDP in Q3 2018 and has held it in 29 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- ALPS Advisors held 1,109 shares of Medpace worth $587K as of Q2 2026.
- ALPS Advisors bought 10 Medpace shares in Q2 2026, an estimated $4.62K.
- Medpace made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #909 holding.
- ALPS Advisors first reported a position in Medpace in Q3 2018 and has held it in 29 quarters since.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.